Digital tech boosted Pfizer commercial, R&D gains during Covid — and there’s no going back, execs say

Beth Snyder Bulik

Senior Editor

Pfizer went digital in a big way during the Covid pandemic — and it’s not going back, executives said at Cowen’s annual healthcare conference on Monday …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Digital tech boosted Pfizer commercial, R&D gains during Covid — and there’s no going back, execs say

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

BridgeBio shares promising results in trial of Canavan disease gene therapy

CRISPR therapy reduces swelling attacks by 81% in Intellia follow-up study

Facing lost rebates, MGM Resorts to stop covering GLP-1 weight loss shots

Exclusive: University of Toronto spinout raises $53.5M to create new obesity drugs with AI

Icon's quarterly earnings hit by biotech and pharma pullback

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

Dig­i­tal tech boost­ed Pfiz­er com­mer­cial, R&D gains dur­ing Covid — and there’s no go­ing back, ex­ecs say

Senior Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Digital tech boosted Pfizer commercial, R&D gains during Covid — and there’s no going back, execs say